Echinococcus Granulosus IgG ELISA

$359.00
Catalog
20-EGGHU-E01
The Echinococcus IgG Enzyme Immunoassay Kit provides materials for the qualitative and semiquantitative determination of IgG-class antibodies to Echinococcus in human serum and plasma. FDA Registered. For In Vitro Diagnostic Use.
Species
Human
Regulatory Status
FDA Registered. For In Vitro Diagnostic Use.
Product Distribution
Available Worldwide
Range
pos./ neg. / cut off control
Sizes
96 Wells
Sample Types
Serum
Inc Time Minute
20
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
10
Detection
Colorimetric
Echinococci are microscopic cestodes (tapeworms) with a length of 1.4 to 6 mm which are dependenton the genus found.  • either in dogs or other canids (E. granulosus)  • or in foxes, coyotes and wolves (E. multilocularis)  Sources of infection are final hosts (i.e. dogs for E. granulosus and mainly foxes for E. multilocularis)and food contaminated with parasite eggs.After ingestion of a suitable intermediate host, the egg hatches in the small bowel and releases anoncosphere that penetrates the intestinal wall and through the circulatory system into various organswhere it develops into a cyst. Echinococcus infections remain silent for years before the enlarging cystscause symptoms in the affected organsE. granulosus larvae (oncospheres) begin to vesiculate mainly in the liver but also in the lungs and inother organs (20%). The parasites form spherical, unilocular, fluid-filled cysts and can achievediameters between 1-15 cm.In contrast to cystic echinococcosis, E. multilocularis larvae are found almost exclusively (98%) in theliver, but secondary lesions can spread metastatically to other organs (lungs, kidneys, CNS andothers). The parasites grow infiltrative and tumor-like in the host tissue.E. granulosus occurs practically worldwideE. multilocularis occurs in the northern hemisphere, including central Europe and the northern parts ofEurope, Asia, and North America.  

Echinococcus Granulosus IgG ELISA

20-EGGHU-E01

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

ALPCO AAAAI 2024
ALPCO at 2024 American Academy of Allergy, Asthma & Immunology(AAAAI) Annual Meeting
As the exclusive North American distributor for Macro Array Diagnostics (MADx), ALPCO is excited to participate in the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC.
View Now
Biomarker Monitoring for the Management of Crohn’s Disease
[Infographic] Biomarker Monitoring for the Management of Crohn’s Disease
This infographic distills the essence of the new American Gastroenterological Association (AGA) Clinical Practice Guideline on the Role of Biomarkers in Crohn's Disease (CD). It sheds light on the nuanced recommendations for using biomarkers to monitor and evaluate CD, emphasizing their value in...
View Now
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
Salem, NH, December 19, 2023 – American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) diagnostic...
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.